
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
T | Toronto | CAD | Real-time | |
TU | NYSE | USD | Real-time | |
T | NEO | CAD | Real-time | |
BCZ | Frankfurt | EUR | Delayed |
We’re hardly in a market downturn. The Canadian stock market has declined about 7.5% from its 52-week high. The U.S. stock correction has it worse — it’s down approximately 15%....
VANCOUVER – TELUS (TSX: T, NYSE: TU) announced today the investment of $17 billion in network infrastructure, operations, and spectrum across Alberta over the next four years and has committed to...
IN8bio recently unveiled expansion of its DeltEx gamma-delta T cell platform capabilities to include induced pluripotent stem cells (iPSCs). Yesterday, at the American Society for Gene & Cell Therapy...
BERKELEY, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the...
Phio Pharmaceuticals Corp (NASDAQ: PHIO) presented new preclinical data showing that silencing BRD4 with PH-894 can improve the quality and potency of HER2-targeted CAR-T cells in a CAR-T expansion...
BERLIN (Reuters) – Germany is considering supplying IRIS-T SLM medium range surface-to-air defence systems to Ukraine, a security source said on Friday.
SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ:SANA), a company focused on creating and delivering engineered cells as medicines, today announced that its Senior Vice...
Favorable safety profile, high overall response and complete response rates, and CAR T persistence observed in patients with relapsed or refractory follicular lymphoma Data to be presented by Fred...
ZUG, Switzerland and CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
-- 100% ORR (5 of 5 patients) and 80% CR (4 of 5 patients) achieved following 1 dose at the initial dose level in patients with aggressive r/r B-NHL -- -- CB-010 is the 1st allogeneic CAR-T cell...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review